Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name GSK2636771
Trade Name
Synonyms GSK-2636771|GSK 2636771
Drug Descriptions

GSK2636771 is a selective inhibitor of PIK3CB, which potentially increases apoptosis and decreases growth in tumors expressing PI3K beta (PMID: 28645941, PMID: 31371342).

DrugClasses PIK3CB inhibitor 8
CAS Registry Number 1372540-25-4
NCIT ID C106261

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
A66 + GSK2636771 A66 GSK2636771 1 0
Alpelisib + Encorafenib + GSK2636771 Alpelisib Encorafenib GSK2636771 1 0
Alpelisib + GSK2636771 Alpelisib GSK2636771 1 0
Binimetinib + GSK2636771 Binimetinib GSK2636771 2 0
Encorafenib + GSK2636771 Encorafenib GSK2636771 2 0
Encorafenib + GSK2636771 + unspecified IGF-1R antibody Encorafenib GSK2636771 unspecified IGF-1R antibody 1 0
Enzalutamide + GSK2636771 Enzalutamide GSK2636771 1 0
GSK2636771 GSK2636771 8 2
GSK2636771 + NVP-AEW541 GSK2636771 NVP-AEW541 2 0
GSK2636771 + Paclitaxel GSK2636771 Paclitaxel 1 0
GSK2636771 + Pembrolizumab GSK2636771 Pembrolizumab 1 1
GSK2636771 + unspecified IGF-1R antibody GSK2636771 unspecified IGF-1R antibody 1 0
GSK2636771 + unspecified PD-1 antibody GSK2636771 unspecified PD-1 antibody 1 0


Additional content available in CKB BOOST